Glucon Medical Ltd. Announces Milestone Patent For Photoacoustic Assay And Imaging System For The Treatment Of Diabetes
10/19/2005 5:12:44 PM
BOULDER, Colo.--(BUSINESS WIRE)--Feb. 15, 2005--Glucon (www.glucon.com), developer of a continuous, noninvasive, glucose monitoring technology for home and clinical use, announced today the granting of U.S. Patent No. 6,846,288, issued on January 25, 2005 for the use of photoacoustic waves originating in a specific region (a blood vessel) to calculate the concentration of a component (glucose) in the blood vessel. The patent was granted to Glucon's founders, Company President Mr. Ron Nagar and V.P. of R&D, Dr. Benny Pesach.
comments powered by